Published in Br J Clin Pharmacol on April 01, 1975
Once-daily dosing with Atenolol in patients with mild or moderate hypertension. Br Med J (1976) 3.64
Effect of atenolol on ventilatory and cardiac function in asthma. Br Med J (1976) 1.60
The role of beta-adrenoceptors in the responses of the hepatic arterial vascular bed of the dog to phenylephrine, isoprenaline, noradrenaline and adrenaline. Br J Pharmacol (1977) 1.47
Investigation of the mechanism of propranolol-induced bronchoconstriction. Br J Pharmacol (1979) 1.27
Haemodynamic effects of atenolol in patients with coronary artery disease. Br Heart J (1978) 0.96
Effects of selective and non-selective beta-adrenergic blockade on coronary dynamics in man assessed by rapid atrial pacing. Br Heart J (1978) 0.88
Beta-adrenoceptor blocking effects and pharmacokinetics of betaxolol (SL 75212) in man. Br J Clin Pharmacol (1980) 0.84
Comparative beta-adrenoceptor blocking effects and pharmacokinetics of penbutolol and propranolol in man. Br J Clin Pharmacol (1977) 0.80
A comparison of the bronchoconstrictor and beta-adrenoceptor blocking activity of propranolol and acebutolol. Br J Pharmacol (1980) 0.79
Effect of CGP 17/582, a selective beta-adrenoceptor antagonist, on the haemodynamic and hypokalaemic response to adrenaline. Br J Clin Pharmacol (1989) 0.78
Effects of atropine on heart-rate in healthy man. Lancet (1967) 5.10
Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man. Br Med J (1970) 3.80
A new type of cardioselective adrenoceptive blocking drug. Br J Pharmacol (1973) 3.65
The action of ICI-66082 on the heart. Br J Pharmacol (1973) 2.15
New approach to assessment of cardioselectivity of beta-blocking drugs. Br Med J (1974) 2.06
The actions of a new beta-adrenoceptor blocking drug, ICI 66082, on the rabbit papillary muscle and on the dog heart. Br J Pharmacol (1974) 2.03
Blood levels of practolol after oral and parenteral administration and their relationship to exercise heart rate. Clin Pharmacol Ther (1974) 1.81
Blockade of peripheral vascular responses to isoprenaline by three beta-adrenoceptor antagonists in the anaesthetized dog. Br J Pharmacol (1974) 1.79
Effects of atropine on heart rate and oxygen intake in working man. J Appl Physiol (1953) 1.66
The blocking effects of propranolol, practolol and ICI-66082 on the peripheral vascular responses to isoprenaline. Br J Pharmacol (1973) 1.62
Effect of route of administration on the relationship between -adrenergic blockade and plasma propranolol level. Clin Pharmacol Ther (1972) 1.48
Proceedings: Preliminary observations on the human pharmacology of I.C.I. 66082 in normal volunteers. Br J Pharmacol (1973) 1.29
An investigation of the relationship between beta-adrenoceptor blockade and plasma practolol concentration in man. Eur J Clin Pharmacol (1974) 1.14
Reminders to physicians from an introspective computer medical record. A two-year randomized trial. Ann Intern Med (1984) 15.06
A role for glucagon-like peptide-1 in the central regulation of feeding. Nature (1996) 6.03
Effects of atropine on heart-rate in healthy man. Lancet (1967) 5.10
Effect of homeopathic treatment on fibrositis (primary fibromyalgia) BMJ (1989) 5.00
Localization of the human alpha-globin structural gene to chromosome 16 in somatic cell hybrids by molecular hybridization assay. Cell (1977) 4.34
ACTIVE: a cognitive intervention trial to promote independence in older adults. Control Clin Trials (2001) 4.27
Characterization of a membrane receptor for transforming growth factor-beta in normal rat kidney fibroblasts. J Biol Chem (1984) 4.20
Stimulation of steroidogenesis in tissue culture by enterotoxigenic Escherichia coli and its neutralization by specific antiserum. Infect Immun (1974) 4.19
Bullying in schools: self reported anxiety, depression, and self esteem in secondary school children. BMJ (1998) 4.14
Some characteristics of homosexual men. Br J Vener Dis (1976) 4.00
The effects of a new beta-adrenoceptive receptor blocking drug on heart rate in man. Br J Pharmacol Chemother (1968) 3.95
Latent transforming growth factor-beta from human platelets. A high molecular weight complex containing precursor sequences. J Biol Chem (1988) 3.91
Mucosal adherence of human enteropathogenic Escherichia coli. Lancet (1975) 3.54
Purification and initial characterization of a type beta transforming growth factor from human placenta. Proc Natl Acad Sci U S A (1983) 3.52
Conformational change in the DNA associated with an unusual promoter mutation in a tRNA operon of Salmonella. Cell (1984) 3.44
Stimulation of cAMP response element (CRE)-mediated transcription during contextual learning. Nat Neurosci (1998) 3.33
The effect of propranolol on anxiety. Lancet (1966) 3.33
The Radical Cure of Inguinal Hernia in Children. Proc R Soc Med (1912) 3.29
Preliminary investigations of a new beta-adrenoceptive receptor blocking drug, LB46, in man. Br J Pharmacol (1969) 3.25
Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: intrinsic stability predicts lifelong persistence. Proc Natl Acad Sci U S A (2003) 2.95
Distribution and modulation of the cellular receptor for transforming growth factor-beta. J Cell Biol (1987) 2.87
Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med (1994) 2.80
Differences in human alpha-, beta- and delta-globin gene expression in monkey kidney cells. Cell (1982) 2.78
Chromosomal localization of human beta globin gene on human chromosome 11 in somatic cell hybrids. Proc Natl Acad Sci U S A (1978) 2.65
Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo. J Biol Chem (2001) 2.58
Adrenomedullin, a multifunctional regulatory peptide. Endocr Rev (2000) 2.52
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
Sensitive method for the routine determination tricyclic antidepressants in plasma using a specific nitrogen detector. J Chromatogr (1975) 2.48
Genetic factors in determining bone mass. J Clin Invest (1973) 2.35
Studies of the interaction of desmethylimipramine with tyramine in man after a single oral dose, and its correlation with plasma concentration. Br J Clin Pharmacol (1976) 2.29
The effect of age on plasma levels of propranolol and practolol in man. Br J Clin Pharmacol (1975) 2.28
Long-term health effects in hamsters and rats exposed chronically to man-made vitreous fibres. Ann Occup Hyg (1987) 2.23
The socioemotional development of 5-year-old children of postnatally depressed mothers. J Child Psychol Psychiatry (1999) 2.23
Plasma concentrations of fenfluramine and its metabolite, norfenfluramine, after single and repeated oral administration. Br J Pharmacol (1971) 2.23
The severity of asthma in relation to beta agonist prescribing. N Z Med J (1991) 2.20
Talking about drugs - the role of the clinical pharmacologist. J R Soc Med (1982) 2.15
A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo. Endocrinology (1998) 2.14
Cardiac and pulmonary effects of acebutolol. Lancet (1975) 2.12
The interactions of local guanethidine and sympathomimetic amines in the human eye. Arch Ophthalmol (1969) 2.09
Effect of adrenergic receptor blockade of the tachycardia of thyrotoxicosis and anxiety state. Lancet (1965) 2.09
Critical flicker frequency and centrally-acting drugs. Br J Ophthalmol (1968) 2.08
Studies of cardioselectivity and partial agonist activity in beta-adrenoceptor blockade comparing effects on heart rate and peak expiratory flow rate during exercise. Br J Clin Pharmacol (1978) 2.07
A simple method to measure drug effects on human sperm motility. Br J Clin Pharmacol (1981) 2.06
New approach to assessment of cardioselectivity of beta-blocking drugs. Br Med J (1974) 2.06
Epithelial-mesenchymal signaling during the regionalization of the chick gut. Development (1998) 2.05
Adrenergic blockade and the eye signs of thyrotoxicosis. Lancet (1966) 2.02
Relative potencies of sympathetic amines in human smooth muscle. Br J Pharmacol (1969) 1.98
Intravenous tyramine pressor response in depression. Lancet (1975) 1.98
The transcription factor Pitx2 mediates situs-specific morphogenesis in response to left-right asymmetric signals. Cell (1998) 1.95
Some central and peripheral effects of meclastine, a new antihistaminic drug, in man. J Clin Pharmacol New Drugs (1971) 1.94
Action of fenfluramine on isolated human smooth muscle. Lancet (1969) 1.94
Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice. J Clin Invest (1997) 1.89
The inhibitory action of procaine, (+)-propranolol and (+/-)-propranolol on human sperm motility: antagonism by caffeine. Br J Clin Pharmacol (1981) 1.88
Written information given to patients and families by palliative care units: a national survey. Lancet (2000) 1.88
Some clinical pharmacological studies with terfenadine, a new antihistamine drug. Br J Clin Pharmacol (1978) 1.86
Encouraging primary care physicians to help smokers quit. A randomized, controlled trial. Ann Intern Med (1989) 1.86
Resting cerebral blood flow: a potential biomarker of the effects of HIV in the brain. Neurology (2009) 1.83
The bioavailability of quinine. J Trop Med Hyg (1976) 1.80
Comparison of ipratropium bromide and salbutamol by aerosolized solution. Aust N Z J Med (1981) 1.77
Class experiment in clinical pharmacology with benzilonium bromide, an anticholinergic drug. Eur J Clin Pharmacol (1974) 1.72
International trial of long-term dexfenfluramine in obesity. Lancet (1989) 1.70
A comparison of the effects of chlorphentermine, diethylpropion and phenmetrazine on critical flicker frequency. Br J Pharmacol Chemother (1967) 1.70
Inadequacy of iridium implant as sole radiation treatment for operable breast cancer. Eur J Cancer (1996) 1.70
Prescription of benzodiazepines in a London teaching hospital. J R Soc Med (1990) 1.69
Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy. J Virol (2005) 1.68
Autonomic actions and interactions of mianserin hydrochloride (Org. GB 94) and amitriptyline in patients with depressive illness. Psychopharmacology (Berl) (1976) 1.68
Glucagon-like peptide-1 is a physiological incretin in rat. J Clin Invest (1995) 1.66
Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients. Eur Respir J (2006) 1.64
Active conformation of the globin genes in uninduced and induced mouse erythroleukemia cells. Cell (1978) 1.64
The loss of bone mineral with aging and its relationship to risk of fracture. J Clin Invest (1975) 1.61
Selectivity of beta adrenoreceptor antagonist drugs assessed by histamine bronchial provocation. Clin Pharmacol Ther (1979) 1.60
Alpha receptor blockade by thymoxamine in the human eye. Clin Pharmacol Ther (1968) 1.60
Disposition of oral metronidazole in hepatic cirrhosis and in hepatosplenic schistosomiasis. Gut (1982) 1.59
Cloning and expression profiling of Hpa2, a novel mammalian heparanase family member. Biochem Biophys Res Commun (2000) 1.59
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Absorption of propranolol and practolol in Coeliac disease. Gut (1976) 1.55
Bile duct injury during laparoscopic cholecystectomy: a report of the Standards Sub-committee of the Victorian State Committee of the Royal Australasian College of Surgeons. Aust N Z J Surg (1993) 1.53
The social work externship. J R Coll Gen Pract (1973) 1.53
Counseling medical and dental patients about cigarette smoking: the impact of nicotine gum and chart reminders. Am J Public Health (1987) 1.53
Multisite randomized controlled trials in health services research: scientific challenges and operational issues. Med Care (2001) 1.52
Recombinant TGF-beta 1 is synthesized as a two-component latent complex that shares some structural features with the native platelet latent TGF-beta 1 complex. Growth Factors (1989) 1.51
The Treatment of a Denture, Swallowed and Impacted in the OEsophagus, by means of Killian's OEsophageal Tube. Proc R Soc Med (1909) 1.51
Hospital antibiotic prescribing successfully modified by 'immediate concurrent feedback'. Br J Clin Pharmacol (1996) 1.51
Meta-analysis of large outcome trials of angiotensin receptor blockers in hypertension. J Hum Hypertens (2006) 1.47
Explanation for potency of repeated oral doses of morphine? Lancet (1987) 1.47
Proceedings: Effect of fenfluramine and norfenfluramine on glucose uptake by the isolated rat diaphragm. Br J Pharmacol (1974) 1.46
In vivo measurement of bone mass in the radius. Metabolism (1968) 1.46
The microenvironment of the human antral follicle: interrelationships among the steroid levels in antral fluid, the population of granulosa cells, and the status of the oocyte in vivo and in vitro. J Clin Endocrinol Metab (1979) 1.45
Rapid mass spectrometric peptide sequencing and mass matching for characterization of human melanoma proteins isolated by two-dimensional PAGE. Proc Natl Acad Sci U S A (1995) 1.45
A comparison of the effects of propranolol and practolol on forced expiratory volume and resting heart rate in normal subjects. Arch Int Pharmacodyn Ther (1971) 1.45
Intravenous treatment with rimiterol and salbutamol in asthma. Br Med J (1975) 1.45
Chlortenoxicam pharmacokinetics in young and elderly human volunteers. Postgrad Med J (1988) 1.45
Toward common ground. Diabetes Care (1997) 1.43